From molecule to medicine! - Novartis discuss dry powder inhalation at COPD 2015

Now in its 7th year, the industry established conference on COPD will return to London on 19th and 20th October to discuss the latest advancements in Novel therapeutics and management strategies
By: SMi Group
 
 
COPD 2015
COPD 2015
LONDON - June 19, 2015 - PRLog -- Now in its 7th year, COPD 2015 will gather a global audience of respiratory experts and scientific pioneers to discuss the latest developments in combinational therapies, new drugs and personalised treatment as well as the challenges of clinical trials.

This years agenda will address questions such as: How does one reliably recruit and run clinical trials in a disease that branches to such extremes? What is the correct phenotype to measure in the disease? With the majority of COPD patients on varying courses of polypharmacy due to a range of different debilitating diseases alongside COPD – how can one find a clean patient?

Highlights will include a keynote address from Dr Frank Thielmann, the Operational Lead in Inhalation New Solids from Novartis. The presentation on formulation development and manufacturing will discuss drug properties and challenges in the manufacturing of DPI systems, as well as provide unique insight into future trends in inhaled drug delivery.

Other key speakers include:

Philip Silkoff, Senior Medical Director, Johnson and Johnson Pharmaceutical Services LLC
Stefano Petruzzelli
, Chief Medical Officer and Director, Global Clinical Development, Chiesi Farmaceutici S.p.A
Sanjeeva Dissanayake
, Head of Medical Sciences – Respiratory, Mundipharma
Noel Snell
, Director of Research, British Lung Foundation
Geoff Down
, Chief Medical Officer, Prosonix
Konstantinos Kostikas
, Medical Director Respiratory COPD Region Europe, Novartis Pharma
Thomas Schlange
, Senior Biomarker Expert, Bayer
Matthew Sleeman, Senior Director of Biology, Respiratory, Inflammation and Autoimmunity, MedImmune

For those who are interested in attending there is currently a £400 discount available online. For further details visit the website.

COPD
19th & 20th October 2015
Holiday Inn Regents Park Hotel, London UK
http://www.smi-online.co.uk/pharmaceuticals/uk/copd-novel...
Sponsored by Quintiles

---END---

About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Contact
Teri Arri
***@smi-online.co.uk
End
Source:SMi Group
Email:***@smi-online.co.uk
Posted By:***@smi-online.co.uk Email Verified
Tags:Copd, Respiratory, Lung, Inhaled Drugs, Exacerbations
Industry:Health, Medical
Location:London City - London, Greater - England
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
SMi Group Ltd. News
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share